dihydroxyphenylalanine has been researched along with Neoplasms, Bone Marrow in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piccardo, A | 1 |
| Lopci, E | 1 |
| Foppiani, L | 1 |
| Morana, G | 1 |
| Conte, M | 1 |
1 other study available for dihydroxyphenylalanine and Neoplasms, Bone Marrow
| Article | Year |
|---|---|
(18)F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma.
Topics: Bone Marrow Neoplasms; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Induction Chemother | 2014 |